Tags: US | DOJ | J&J

Two J&J Subsidiaries Agree to Settle on Epilepsy Drug

Thursday, 29 Apr 2010 12:33 PM

The Justice Department says two subsidiaries of pharmaceutical giant Johnson & Johnson have agreed to pay more than $81 million stemming from allegedly illegal promotion of the epilepsy drug Topamax.

The department says Ortho-McNeil Pharmaceutical LLC will plead guilty to promoting the sale of Topamax for psychiatric uses. Federal drug regulators approved it as an anti-epileptic drug.

The government says Ortho-McNeil-Janssen Pharmaceuticals will pay over $75 million for alleged illegal promotion of Topamax for a variety of psychiatric uses.

© Copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

1Like our page

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

America's News Page
©  Newsmax Media, Inc.
All Rights Reserved